top of page

Gender-Lens Impact Enterprises

These social enterprises recognize women as key agents of change — as social entrepreneurs, innovators, and leaders. They address systemic barriers that limit access to healthcare, finance, education, and opportunity, while creating products and services that improve the lives of their communities.

From healthcare access and educational platforms to regenerative agriculture and social entrepreneurship, each of these ventures demonstrates how empowering women strengthens economies, builds resilience, and drives lasting impact. 

Medicines_edited.jpg

An e-pharmacy operator, that combines an online pharmacy platform with a network of partner pharmacies to deliver prescription and over-the-counter medications efficiently and affordably.

image.png
Uganics.jpg

A mission-driven social enterprise dedicated to fighting malaria through innovation embedded in daily life.

image.png
Schermafbeelding 2025-10-07 125634.png

A platform that deploys innovative, tech-enabled solutions to expand access to quality healthcare in underserved peri-urban and rural communities across Africa.

image.png
TxC.jpg

A social enterprise focused on breaking cycles of poverty through inclusive value chains and local empowerment.

image.png
Hear me.webp
image.png

A social-tech startup advancing communication equity through sign language translation and inclusion tools.

Happy grounds.webp

A regenerative agriculture and climate innovation venture that supports smallholder farmers while enabling corporate-level climate action.

image.png

Happy Ground

aloi 2.png

A digital finance platform that empowers micro and informal sector entrepreneurs by enforcing transparency and traceability in lending and disbursement.

image.png

Past Portfolio Companies

Through our revolving funding model, We Share Forward Foundation co-funded Olgram and Betathera, two companies incubated by Medicines Discovery Catapult. This kick-started the discovery of new drug treatments focused on antimicrobial resistance for cystic fibrosis patients whose clinical needs were not being met.

catapult medicines discovery
betathera
olgram
cittamap
de krekerij

De Krekerij

Treety
bottom of page